Dynamic assessment of serum chromogranin A and treatment response with abiraterone acetate in metastatic castration-resistant prostate cancer.

Lewis, Akeem R; Costello, Brian A; Quevedo, Fernando; Pagliaro, Lance C; Sanhueza, Cristobal; Weinshilboum, Richard M; Kalari, Krishna R; Wang, Liewei; Kohli, Manish; Tan, Winston; Giridhar, Karthik V

Lewis, Akeem R; Costello, Brian A; Quevedo, Fernando; Pagliaro, Lance C; Sanhueza, Cristobal; Weinshilboum, Richard M; Kalari, Krishna R; Wang, Liewei; Kohli, Manish; Tan, Winston; Giridhar, Karthik V.

Afiliação

Lewis AR; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Costello BA; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Quevedo F; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Pagliaro LC; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Sanhueza C; Department of Oncology, Clínica Santa María, Santiago, Chile.
Weinshilboum RM; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
Kalari KR; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, USA.
Kohli M; Department of Internal Medicine, Huntsman Cancer Institute, Division of Oncology, University of Utah, Salt Lake City, Utah, USA.
Tan W; Department of Medicine, Mayo Clinic, Jacksonville, Florida, USA.
Giridhar KV; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA.

Prostate ; 83(7): 649-655, 2023 05.

Article em En | MEDLINE | ID: mdl-36924119

Assuntos

Acetato de Abiraterona; Neoplasias de Próstata Resistentes à Castração; Humanos; Masculino; Acetato de Abiraterona/uso terapêutico; Protocolos de Quimioterapia Combinada Antineoplásica; Cromogranina A; Cromograninas; Estudos Prospectivos; Antígeno Prostático Específico; Neoplasias de Próstata Resistentes à Castração/patologia; Estudos Retrospectivos; Resultado do Tratamento

Palavras-chave

abiraterone acetate; castrate resistant; chromogranin; prostate cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias de Próstata Resistentes à Castração / Acetato de Abiraterona Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Revista: Prostate Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google